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Conclusions: The ERG test triggered epicardial coronary spasm in more than 40% of
Japanese patients who underwent diagnostic angiography for assessment of stable angina
and unobstructed coronary arteries. Our results suggest that abnormal coronary vasomo-
tion plays pathogenic role in this setting and that the ERG test might be useful to identify
patients with cardiac symptoms, despite normal coronaries.
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Background: We assume that patients (pt) showing positive acetylcholine (Ach)
provocation test to lower Ach dose may more vulnerable to CAS. We investigated
whether there are differences in angiographic characteristics according to Ach dose
causing significant CAS during intracoronary Ach provocation test.
Methods: A total 1730 consecutive pts underwent Ach provocation test by incremental
doses of 20, 50, 100 were enrolled. Significant CAS was defined as focal or diffuse severe
transient luminal narrowing (70%) with/without chest pain or ST-T change on ECG.
Angiographic characteristics were compared between the Low dose group (20 & 50 ug,
n716) and High dose group (100 ug, n1014) among pts with positive Ach provocation
test.
Results: Baseline clinical characteristics were similar between the two groups except the
Low dose group had more elderly ( 50 years), diabetes mellitus and previous myocardial
infarction (MI). During the Ach provocation test, the incidence of atrio-ventricular (AV)
block, severe CAS (70% stenosis by QCA), multi-vessel spasm and diffuse spasm were
more frequent in low dose group (Table).
Conclusions: In our study, we found that pts showing significant CAS to lower Ach dose
showed more chance to have severe, diffuse and mulitvessel spasm during the test. Special
care with intensive medical therapy should be considered who showed significant Ach
response to lower Ach dose as compared with those responded to higher Ach dose.
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Background: Beta blockers (BB) are widely used to control hypertension. It is well
known that BB may lead to significant vasospasm. However, the impact of chronic
administration of BB on clinical and angiographic characteristics during acetylcholine
(Ach) provocation test is not clarified yet.
Methods: A total 3034 consecutive patients (pts) underwent coronary angiography with
Ach provocation test from January 2004 to August 2010 were enrolled for this study. Ach
was injected in incremental doses of 20, 50, 100g into the left coronary artery.
Significant coronary artery spasm (CAS) was defined as focal or diffuse severe transient
luminal narrowing (70%) with/without chest pain or ST-T change on ECG. A total 1394
pts (45.9%) showed positive provocation tests. Among the (	) provocation test pts, we
compared the clinical and angiographic characteristics of patients with beta-blocker to
those without beta-blocker in pts with myocardial infarction.
Results: The baseline clinical and procedural characteristics are well balanced between the
two groups. There was no difference in the incidence of myocardial bridges, chest pain,
ischemic ECG changes and atrioventricular (AV) block on ECG, incidence of baseline spasm,
severe vasospasm, multi-vessel involvements during the Ach provocation test were similar in
both groups
Conclusions: The use of beta blocker in pts with vasospastic angina was not associated
with worse clinical and angiographic parameters during the Ach provocation test. BB may
be safely used in pts with vasospastic angina.
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Background: The recent study has shown that an implantation of sirolimus-eluting stent
(SES) is associated with late restenosis, i.e., late catch-up phenomenon. We investigated
long-term angiographic outcome in patients with vasospastic angina (VSA) treated with the
SES.
Methods: Subjects were patients who had undergone an ergonovine-provocation test for
chest pain, and were subsequently treated with an SES or bare-metal stent (BMS) because of
a progression of coronary artery stenosis. Patients were divided into four groups: SES with
vasospasm (SES-V, n26); SES without vasospasm (SES-NV, n53); BMS with vasospasm
(BMS-V, n28); and BMS without vasospasm (BMS-NV, n46). Coronary angiography
was performed at 8 months (mid-term follow-up) and 20 months (long-term follow-up) after
the implantation of the stent.
Results: As shown in the figure, the SES implantation was associated with a reduction
of minimum lumen diameter (MLD) at the long-term follow-up, indicating late catch-up
phenomenon. This phenomenon was more obvious in patients with VSA than in those
without (p0.05). Both BMS groups showed a reduction in MLD at the mid-term
follow-up compared with immediately after the intervention. This reduction had regressed
at the long-term follow-up, and that was unrelated to VSA. The rate of stent edge
restenosis compared with stent body restenosis in the SES-V group (87.3%) was higher
than that in the SES-NV group (25.0%, p0.05), suggesting the association of vasospasm
with stent restenosis.
Conclusions: The SES implantation may be associated with high rate of late restenosis
in patients with vasospastic angina.
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Background: Spontaneous coronary artery dissection (SCAD) is a rare cause of
ischemic disease.It occurs frequently in young population with predilection for women-
.Real incidence is probably underestimated.
Methods: we analyzed angiographic aspects and risk factors of consecutive Pts
underwent coronary angiography and discharged by our Division with diagnosis of SCAD
from January 1999 to June 2008.
Results: We observed an angiographic aspect of SCAD in 33/10073 pts(0.33%): 21
women(64%).Mean age 50.8 yy.The cause of admission:STEMI in 9 Pts
(27.7%),NSTEMI in 16(48.3%),subacute myocardial infarction in 2(6%), angina or
positive stress test in 6(18%). One vessel disease in 31 Pts.SCAD of anterior descending
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